Word

Status

Pending

Status Code

630

Status Date

Thursday, February 15, 2024

Serial Number

79389701

Mark Type

3

Filing Date

Friday, December 29, 2023

Trademark Owner History

Ribocure Pharmaceuticals AB

Classifications

5 Medicines for human purposes; crude drugs; pharmaceutical preparations; chemico-pharmaceutical preparations; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; drugs for medical purposes; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; medicinal preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; anticoagulants; cardiovascular pharmaceutical preparations; pharmaceutical preparations for ocular or intraocular surgery; depuratives; medicines for veterinary purposes; pesticides; medical dressings; composite materials for dental purposes; diapers for pets

42 Technological research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; pharmaceutical research and development services; scientific research; chemical research and analysis; development and test of chemical production methods; biochemical research and analysis; development of pharmaceutical preparations and medicines; clinical trials; medical research; testing of pharmaceuticals; industrial design

The mark is made of a figurative fancy element in black and orange and of the word ?Ribocure Pharmaceuticals AB? written in black color, where the letters ?i? and ?o? of the word ?Ribocure? are partially in orange.
The color(s) orange and black is/are claimed as a feature of the mark.

Trademark Events

Apr 13, 2024

New Representative At Ib Received

Feb 27, 2024

Application Filing Receipt Mailed

Feb 15, 2024

Sn Assigned For Sect 66a Appl From Ib

Feb 21, 2024

New Application Office Supplied Data Entered